NDC 71288-108
Cytarabine
Cytarabine
Cytarabine is a Intrathecal; Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Meitheal Pharmaceuticals Inc.. The primary component is Cytarabine.
| Product ID | 71288-108_ba035466-3b01-4e2b-abf5-d876619a2674 |
| NDC | 71288-108 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cytarabine |
| Generic Name | Cytarabine |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS |
| Marketing Start Date | 2020-06-26 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA206189 |
| Labeler Name | Meitheal Pharmaceuticals Inc. |
| Substance Name | CYTARABINE |
| Active Ingredient Strength | 20 mg/mL |
| Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |